SCHEMBL9956437

SCHEMBL9956437

CC(C)(C)OC(=O)NCCNC(=O)c1cccc2c1-c1ccccc1C2CO

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KCNA5 P22460 1/20 0.47
MALT1 Q9UDY8 1/20 0.45
ALDH1A1 P00352 1/20 0.42
HTT P42858 1/20 0.42
DDB1 Q16531 1/20 0.40
CRBN Q96SW2 1/20 0.40
TDP1 Q9NUW8 1/20 0.39
BCHE P06276 1/20 0.39
TPSAB1 Q15661 1/20 0.39
TPSD1 Q9BZJ3 1/20 0.39
TPSG1 Q9NRR2 1/20 0.39
CXCR2 P25025 1/20 0.38
PDCD1 Q15116 1/20 0.38
CD274 Q9NZQ7 1/20 0.38
KMT2A Q03164 2/20 0.38
IDO1 P14902 1/20 0.38
MEN1 O00255 1/20 0.38
MAPT P10636 1/20 0.38
MAPK1 P28482 1/20 0.38
HCRTR1 O43613 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9957429 0.81 PTPRC (0.47) KCNA5MALT1ALDH1A1BCHEPDCD1
SCHEMBL28027633 0.79 KCNA5 (0.56) KCNA5MALT1HTTTDP1BCHE
SCHEMBL10085214 0.77 BCHE (0.39) KCNA5MALT1BCHECXCR2KMT2A
SCHEMBL4624902 0.76 ALDH1A1 (0.39) ALDH1A1HTTKMT2AMEN1MAPT
SCHEMBL5557644 0.75 KMT2A (0.60) MALT1BCHEKMT2AIDO1
SCHEMBL1657927 0.74 ESRRG (0.56) KCNA5MALT1ALDH1A1HTTBCHE
SCHEMBL8092638 0.73 HNF4A (0.50) ALDH1A1HTTKMT2AMEN1MAPT
SCHEMBL24439884 0.73 KMT2A (0.43) MALT1TDP1TPSAB1TPSD1TPSG1
SCHEMBL4059012 0.73 HPGD (0.56) KCNA5MALT1ALDH1A1HTTBCHE
SCHEMBL3637629 0.73 MALT1 (0.47) KCNA5MALT1KMT2AIDO1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11406618-B2 Polymer-des-ethyl sunitinib conjugates NEKTAR THERAPEUTICS (US) 2022-08-09 US disclosed
US-20190142798-A1 POLYMER-DES-ETHYL SUNITINIB CONJUGATES NEKTAR THERAPEUTICS 2019-05-16 US disclosed
US-20190142798-A1 POLYMER-DES-ETHYL SUNITINIB CONJUGATES NEKTAR THERAPEUTICS 2019-05-16 US disclosed
US-10220020-B2 Polymer-des-ethyl sunitinib conjugates NEKTAR THERAPEUTICS (US) 2019-03-05 US disclosed
US-10220020-B2 Polymer-des-ethyl sunitinib conjugates NEKTAR THERAPEUTICS (US) 2019-03-05 US disclosed
EP-2654797-B1 POLYMER-DES-ETHYL SUNITINIB CONJUGATES NEKTAR THERAPEUTICS (US) 2017-11-08 EP disclosed
EP-2654797-B1 POLYMER-DES-ETHYL SUNITINIB CONJUGATES NEKTAR THERAPEUTICS (US) 2017-11-08 EP disclosed
US-20140039030-A1 POLYMER-DES-ETHYL SUNITINIB CONJUGATES NEKTAR THERAPEUTICS (US) 2014-02-06 US disclosed
US-20140039030-A1 POLYMER-DES-ETHYL SUNITINIB CONJUGATES NEKTAR THERAPEUTICS (US) 2014-02-06 US disclosed
EP-2654797-A1 POLYMER-DES-ETHYL SUNITINIB CONJUGATES Nektar Therapeutics (US) 2013-10-30 EP disclosed
WO-2012088522-A1 POLYMER-DES-ETHYL SUNITINIB CONJUGATES NEKTAR THERAPEUTICS (US) 2012-06-28 WO disclosed
WO-2012088522-A1 POLYMER-DES-ETHYL SUNITINIB CONJUGATES NEKTAR THERAPEUTICS (US) 2012-06-28 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10220020-B2 Polymer-des-ethyl sunitinib conjugates KDR, FLT4, FLT1 KCNA5 4111/4885MALT1 1439/4885ALDH1A1 3041/4885
US-11406618-B2 Polymer-des-ethyl sunitinib conjugates KDR, FLT4, FLT1 KCNA5 4111/4885MALT1 1439/4885ALDH1A1 3041/4885
US-20140039030-A1 POLYMER-DES-ETHYL SUNITINIB CONJUGATES KDR, FLT4, FLT1 KCNA5 4111/4885MALT1 1439/4885ALDH1A1 3041/4885
US-20190142798-A1 POLYMER-DES-ETHYL SUNITINIB CONJUGATES KDR, FLT4, FLT1 KCNA5 4111/4885MALT1 1439/4885ALDH1A1 3041/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.